Insights into the molecular basis of a bispecific antibody's target selectivity.
Bispecific antibodies constitute a valuable class of therapeutics owing to their ability to bind 2 distinct targets. Dual targeting is thought to enhance biological efficacy, limit escape mechanisms, and increase target selectivity via a strong avidity effect mediated by concurrent binding to both antigens on the surface of the same cell. However, factors that regulate the extent of target selectivity are not well understood. We show that dual targeting alone is not sufficient to promote efficient target selectivity, and report the substantial roles played by the affinity of the individual arms, overall avidity and valence. More particularly, various monovalent bispecific IgGs composed of an anti-CD70 moiety paired with variants of the anti-CD4 mAb ibalizumab were tested for preferential binding and selective depletion of CD4(+)/CD70(+) T cells over cells expressing only one of the target antigens that resulted from antibody dependent cell-mediated cytotoxicity. Variants exhibiting reduced CD4 affinity showed a greater degree of target selectivity, while the overall efficacy of the bispecific molecule was not affected.
a Department of Antibody Discovery and Protein Engineering; MedImmune ; Gaithersburg , MD , USA.
Yariv
Y
Mazor
Anna
A
Hansen
Chunning
C
Yang
Partha S
PS
Chowdhury
Jihong
J
Wang
Geoffrey
G
Stephens
Herren
H
Wu
William F
WF
Dall'Acqua
D018033:Antibodies, Bispecific; D000911:Antibodies, Monoclonal / Q000235:genetics / Q000276:immunology; D000915:Antibody Affinity / Q000235:genetics*; D000918:Antibody Specificity / Q000235:genetics*; D015496:CD4-Positive T-Lymphocytes / Q000276:immunology; D057809:HEK293 Cells; D006801:Humans; D007074:Immunoglobulin G / Q000235:genetics / Q000276:immunology; D008212:Lymphocyte Depletion / Q000379:methods
D018033:Antibodies, Bispecific; D000911:Antibodies, Monoclonal; D007074:Immunoglobulin G; C481504:ibalizumab
ADCC, antibody-dependent cell-mediated cytotoxicity; B cells; CD4; CD70; KD, dissociation constant; PBS, phosphate buffered saline; T cells; affinity; avidity; bispecific antibody; bivalent; bsAb, bispecific antibody; monovalent; selective targeting